Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

NCT00004215

Conditions: Agranulocytosis, Anemia, Blood Platelet Disorders, +18 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

NCT00005634

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +65 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

NCT00066599

Conditions: Agranulocytosis, Blast Crisis, Blood Protein Disorders, +89 more
Locations: Children's Hospital of Orange County Orange, California, United States

Children's Hospital and Health Center, San Diego San Diego, California, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS

NCT00195000

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Weill Medcial College of Cornell University New York, United States

View Trial Details

Completed

PS-341 in Treating Patients With Hematologic Cancer

NCT00006098

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +46 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation

NCT01608204

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

NCT00045422

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00077467

Conditions: Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, Bone Marrow Diseases, +24 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT00081133

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

NCT00003934

Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), Childhood Acute Promyelocytic Leukemia (M3), +10 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions